Kursinformationen (Nasdaq)
- Tagestief / Hoch-
- 52W-Tief / Hoch92,890-125,015
- Jahrestief / Hoch75,250-129,290
- Volumen Intraday
Wichtigste Eigenschaften
Werbung
Schnellsuche von
Termine von Neurocrine Biosciences Inc.
- Mai1Neurocrine Biosciences Inc.Q1 2023 Earnings Release
- Aug1Neurocrine Biosciences Inc.Q2 2023 Earnings Release
- Nov6Neurocrine Biosciences Inc.Q3 2023 Earnings Release
Beschreibung
Neurocrine Biosciences Inc is a research-based pharmaceutical company advancing drug candidates in the central nervous system and endocrine-related categories. The company's three late stage clinical programs are elagolix which is hormone releasing antagonist for women's health, opicapone which is an inhibitor for parkinson's patients, and ingrezza for tourette syndrome.
Pivot-Points (Nasdaq)
NameWert
- Pivot-HBOP - R396,530 $
- Pivot-Resist - R295,530 $
- Pivot-High - R194,890 $
- Pivotpunkt93,890 $
- Pivot-Low - S193,250 $
- Pivot-Support - S292,250 $
- Pivot-LBOP - S391,610 $
Passender Service zu Neurocrine Biosciences Inc.
Webinar zu Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc. Kurse
| Name | Kurs | +/- (%) | +/- (abs) | Vortag | Zeit |
|---|---|---|---|---|---|
Wichtige Bewertungskennzahlen
Keine Kennzahlen vorhanden
Passende Produkte
| WKN | Long/Short | KO | Hebel | Laufzeit | Bid | Ask |
|---|
Keine Ergebnisse gefunden
Wertentwicklung (Nasdaq)
0,00 %
Intraday
-0,20 %
1 Woche
-8,97 %
1 Monat
-21,09 %
Seit Jahresbeginn
1,20 %
1 Jahr
16,88 %
3 Jahre
11,03 %
5 Jahre
731,86 %
10 Jahre
